Spermidine: Observational Link, Null Trial

The short answer: spermidine’s best-known result is observational: in a 20-year Austrian cohort of 829 people, higher dietary spermidine went with lower mortality. That cannot show that spermidine caused it. The best supplement trial, SmartAge (100 older adults for 12 months), found no significant change in memory or secondary outcomes, and some authors disclosed equity in a spermidine company. Nothing shows a human lifespan benefit. Talk to your doctor before supplementing.

What the evidence shows

Grades follow the rubric; overall grade: Weak.

An earlier, positive pilot

Before SmartAge, a pilot trial (Wirth 2018, Cortex) randomised 30 cognitively intact people aged 60 to 80 with subjective cognitive decline to a spermidine-rich plant extract or placebo for three months. Mnemonic discrimination improved within the spermidine group with a medium effect size (Cohen’s d 0.79, confidence interval 0.01 to 1.55, a range that only just excludes zero), but the between-group contrast the abstract also reports (d 0.77) had a confidence interval that touches zero (0 to 1.53 on the effect size; -0.01 to 0.35 on the raw difference). It was a phase IIa pilot, the authors called for a larger trial, and SmartAge, the larger trial, did not confirm it. The PubMed record we read carries no funding or conflict statement, so we cannot say who paid for it; SmartAge’s authors disclosed equity and roles in a spermidine company (above).

What it costs, and why one number is not enough

A price per study dose is not possible: SmartAge used a wheat-germ extract giving 0.9 mg spermidine a day, and shops list different things (extract weight, salt weight, free spermidine). The table shows what each label states, from brand pages read 29 Sept 2026 (USD, before tax and shipping; arithmetic ours).

Two cautions when comparing. Spermidine trihydrochloride is a salt: free spermidine is about 57% of its weight (molecular weights 145.2 and 254.6, our arithmetic), so 8 mg of salt is roughly 4.6 mg spermidine. And the amounts on the salt products are several times the 0.9 mg used in SmartAge, in a different form; no trial tested them. spermidineLIFE, the priciest here, is made by TLL The Longevity Labs GmbH (its product page), the company named in the SmartAge authors’ disclosures, where one author was chief executive while the trial ran and three others held equity or advisory roles. The abstract does not say which brand supplied the trial extract, so we do not claim any product here is the trial product. Price is the smaller question: the benefit itself is unproven.

Where it fits

Spermidine is a Weak-grade compound in the graded ladder. Compare with fasting, which is often paired with it in the autophagy conversation but has its own evidence limits, and see cost per study dose for compounds with a costable trial dose.

Method note

Researched from PubMed abstract records (29 Sept 2026) and brand pages (28 Sept 2026; Double Wood and Renue By Science prices re-checked 29 Sept 2026, unchanged). Abstracts only; grades are our judgement using the published rubric. We did not test any product. General information, not medical advice.

See also: Longevity supplements with null trials: an evidence ledger.